AzTrials
AzTrials

Low Back PainNCT03671278

Implementation of the STarT Back Screening Tool

A study testing STarT Back Screening Tool Approach in people with Low Back Pain, run by Universidade Cidade de Sao Paulo.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The STarT Back Screening Tool (SBST) has been used in different healthcare settings in order to stratify the management of patients with low back pain. However, to date, no study has investigated the feasibility of implementing the SBST in emergency departments. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Low Back Pain
What is being tested?
STarT Back Screening Tool Approach
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
No sites listed yet
Study dates
Oct 2018to Dec 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • We will include patients with back pain seeking care in emergency departments

Who cannot join

  • We will exclude patients with serious spinal pathologies (such as cancer, fractures, inflammatory and infectious diseases) as well as pregnant patients and patients with nerve root compromise.

Trial locations and contacts

No sites are listed yet.

Luciola Costa, PhD contact

1121781564

luciola.costa@unicid.edu.br

About this study

Official title: Implementing the STarT Back Model of Stratifying Care for Patients With Low Back Pain Seeking Care in an Emergency Department: a Prospective Longitudinal Cohort Study

The STarT Back Screening Tool (SBST) has been used in different healthcare settings in order to stratify the management of patients with low back pain. However, to date, no study has investigated the feasibility of implementing the SBST in emergency departments. The objective of this study will be to test the implementation of the SBST in the stratification of patients seeking care in emergency departments.

Read the detailed description

The Start Back Screening Tool (SBST) aims to identify and stratify primary care patients by using modifiable prognostic indicators that are relevant in clinical decision making. The objective of this study will be to test the feasibility of the implementation of the SBST in the stratification of patients seeking care in emergency departments. Study design: A prospective longitudinal cohort study with a 6-month follow-up. Intervention: At 6-weeks after baseline consultation, patients will be targeted to the specific treatment according to their subclassification in the SBST tool: education about pain neurophysiology and physical therapy. This is the first study that will provide results about logistic processes of the implementation of the SBST in the emergency sector, present feasibility data for the conduction of a large randomized controlled trial of subgroups of low back pain.

Conditions
Low Back Pain
Being tested
STarT Back Screening Tool Approach
Keywords
low back pain, emergency, feasibility, implementation
Medical subject headings
Low Back Pain, Emergencies

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • STarT Back Screening Tool ApproachOther

    Patients classified as low risk of persistent pain will be educated about their condition and how to manage their back pain by targeting modifiable prognostic factors. Patients classified as medium risk will receive evidence-based physical therapy. Patients classified as high risk will receive evidence-based physical therapy as well as individualized psychological intervention.

Study groups in NCT03671278
Study groupRoleWhat they receive
STarT Back Screening Tool ApproachOtherAfter baseline consultation, all patients will receive usual care from their medical doctors as well as an educational booklet and weekly videos containing information on the prognosis of back pain and how patients could deal with their problems. Six weeks after baseline consultation all patients will be screened by the STarT Back Screening Tool (SBST) and will receive a stratified care according to their SBST classification.
Receives: Other: STarT Back Screening Tool Approach

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility from the perspective of the patient

    Feasibility will be measured by using 4 constructs (Adoption, adequacy, feasibility and fidelity). These constructs will be measured by using yes/no questions.

    Measured: Adoption at 6 weeks (i.e. at the implementation of treatment after stratification)

  2. Feasibility from the perspective of the patient

    Feasibility will be measured by using 4 constructs (Adoption, adequacy, feasibility and fidelity). These constructs will be measured by using yes/no questions.

    Measured: Adequacy at 3 months.

  3. Feasibility from the perspective of the patient

    Feasibility will be measured by using 4 constructs (Adoption, adequacy, feasibility and fidelity). These constructs will be measured by using yes/no questions.

    Measured: Fidelity at 3 months.

  4. Feasibility from the perspective of the patient

    Feasibility will be measured by using 4 constructs (Adoption, adequacy, feasibility and fidelity). These constructs will be measured by using yes/no questions.

    Measured: Feasibility at 3 months.

Secondary outcomes (7)
  1. Pain intensity measured by a 0-10 Pain Numerical Rating Scale

    Pain intensity will be measured by an 11-point (0-10) Pain Numerical Rating Scale (Pain NRS). Higher scores indicates higher pain intensity.

    Measured: 1, 2, 6 weeks and 3 and 6 months after first consultation at the emergency department.

  2. Disability measured by the 0-24 Roland Morris Disability Questionnaire

    Disability will be measured by the 24-item Roland Morris Disability Questionnaire. Higher scores indicates higher disability.

    Measured: 6 weeks and 3 and 6 months after first consultation at the emergency department.

  3. Risk of persistent disability measured by the 0-9 Start Back Screening Tool.

    Risk of persistent disability will be measured using the 0-9 point Start Back Screening Tool. The higher the score the higher is the risk of persistent disability.

    Measured: 1, 2, 6 weeks and 3 and 6 months after first consultation at the emergency department.

  4. Global Impression of Recovery measured by the -5 to + 5 Global Perceived Effect Scale.

    Global Impression of Recovery will be measured using the 11-item Global Perceived Effect Scale. Positive values represents recovery and negative values represents deterioration of symptoms.

    Measured: 1, 2, 6 weeks and 3 and 6 months after first consultation at the emergency department.

  5. Recovery from pain

    Recovery from pain will be measured using a yes/no question (i.e. Were you completely free of back pain over the last month?)

    Measured: 1, 2, 6 weeks and 3 and 6 months after first consultation at the emergency department.

  6. Depressive symptoms over the last week.

    Depression will be measured by a single question on how depressed patients were over the last week (measured on a 0-10 likert scale)

    Measured: 1, 2, 6 weeks and 3 and 6 months after first consultation at the emergency department.

  7. Recurrence of low back pain symptoms

    Patients who recovered will be asked if they have experience a recurrence of symptoms

    Measured: 6 weeks and 3 and 6 months after first consultation at the emergency department.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Sep 2018
  2. Study startOct 2018 (estimated)
  3. Primary completionOct 2019 (estimated)
  4. Study completionDec 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03671278
Sponsor's protocol ID
Unicid20
Status last verified
Sep 2018
First submitted
5 Sep 2018
Last updated
14 Sep 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: We can share our dataset upon request.

Questions about this trial

What is this clinical trial studying?

A study testing STarT Back Screening Tool Approach in people with Low Back Pain, run by Universidade Cidade de Sao Paulo.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 14 Sep 2018. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Luciola Costa, PhD (1121781564, luciola.costa@unicid.edu.br), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility from the perspective of the patient (time frame: Adoption at 6 weeks (i.e. at the implementation of treatment after stratification)). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Sep 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in